BioSpace News Archive

Drug Development

Wyeth and Progenics Pharmaceuticals, Inc. to Initiate Phase 2 Trials of Oral Methylnaltrexone in Chronic-Pain Setting

October 15, 2007
·
1 min read
Drug Development

Dynogen Pharmaceuticals, Inc.'s Oral Prokinetic Drug, DDP733, Shown to Reduce Reflux in Phase 1B Study

October 15, 2007
·
1 min read
Drug Development

Xanthus Pharmaceuticals, Inc. Presents Data from FLT3 Autoimmune Program Supporting Novel Cell-Targeted Mechanism for Disease Attenuation

October 15, 2007
·
1 min read
BioForest

Biotechnology Industry Organization (BIO) Investor Forum 2007 Draws Record Crowd of Investment, Biotechnology and Pharmaceutical Leaders

October 15, 2007
·
1 min read
Akela Pharma Inc. Announces U.S. Public Offering and Proposed Listing

October 15, 2007
·
2 min read
BioForest

AVI BioPharma, Inc. Receives Major Research and Development Grant From Charley’s Fund for Duchenne Muscular Dystrophy

October 15, 2007
·
1 min read
Drug Development

Shire Pharmaceuticals Group plc New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG

October 15, 2007
·
10 min read
Deals

Sartorius AG Sells Hydrodynamic Bearings Business to the British Smiths Group

October 15, 2007
·
1 min read
BioMidwest

Study Shows Applied NeuroSolutions, Inc.'s Test is the Strongest Predictor of the Decline from Mild Cognitive Impairment to Alzheimer’s Disease

October 15, 2007
·
1 min read
Drug Development

Critical Therapeutics, Inc. Announces Enrollment in Phase III Trial of Zileuton in Patients with Acute Exacerbations of COPD

October 15, 2007
·
1 min read